Literature DB >> 21502578

Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience.

Kenji Suda1, Motofumi Iemura, Hiroshi Nishiono, Yozo Teramachi, Yusuke Koteda, Shintaro Kishimoto, Yoshiyuki Kudo, Shinichi Itoh, Haruka Ishii, Takafumi Ueno, Tadashi Tashiro, Masakiyo Nobuyoshi, Hirohisa Kato, Toyojiro Matsuishi.   

Abstract

BACKGROUND: Some patients with Kawasaki disease develop giant coronary aneurysms and coronary stenosis, leading to ischemic heart disease. The aim of this study was to determine the long-term prognosis of patients with Kawasaki disease with giant aneurysms. METHODS AND
RESULTS: From our institutional database, 76 patients (57 men and 19 women) who developed giant aneurysms after January 1, 1972, were identified. Information on patient demographics, catheter and surgical interventions, and most recent status was collected from medical charts and patients' contacts. From these data, we calculated the survival rate and cumulative coronary intervention rate. The average age at onset was 2.9±2.9 years, and the median observational period was 19 years. During this period, 7 patients died and 1 patient underwent a heart transplantation, resulting in 95%, 88%, and 88% survival rates at 10, 20, and 30 years after the onset of KD, respectively. On the other hand, catheter and surgical coronary interventions (median, 1 intervention; range, 1 to 7 interventions) were performed to alleviate coronary ischemia in 46 patients (61%) at 1 month to 21 years (mode at 1 month) after onset, resulting in 28%, 43%, and 59% cumulative coronary intervention rates at 5, 15, and 25 years after onset, respectively.
CONCLUSIONS: The long-term survival of patients with Kawasaki disease complicated by giant coronary aneurysms is moderately good with multiple catheter and surgical interventions. Further research should focus on the prevention of coronary vascular remodeling and on the indications for and effectiveness of percutaneous and surgical coronary interventions.

Entities:  

Mesh:

Year:  2011        PMID: 21502578     DOI: 10.1161/CIRCULATIONAHA.110.978213

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

1.  Study design and rationale to assess Doxycycline Efficacy in preventing coronary Artery Lesions in children with Kawasaki disease (DEAL trial) - A phase II clinical trial.

Authors:  Andras Bratincsak; Blair N Limm-Chan; Vivek R Nerurkar; Lauren L Ching; Venu D Reddy; Eunjung Lim; Ralph V Shohet; Marian E Melish
Journal:  Contemp Clin Trials       Date:  2017-12-05       Impact factor: 2.226

2.  Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Authors:  Lori B Daniels; Matthew S Tjajadi; Hannah H Walford; Susan Jimenez-Fernandez; Vera Trofimenko; Daryl B Fick; Hoang-Anh L Phan; Peter E Linz; Keshav Nayak; Andrew M Kahn; Jane C Burns; John B Gordon
Journal:  Circulation       Date:  2012-05-17       Impact factor: 29.690

3.  Coronary artery aneurysms in a 15-year-old boy.

Authors:  Stephen J D'Auria; Meghan Trojan Borden; Sandeep M Patel; Conrad Smith
Journal:  Tex Heart Inst J       Date:  2014-12-01

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

5.  Bioresorbable Vascular Scaffold Implantation for Successful Treatment of a Symptomatic Coronary Lesion in a 17-Year-Old Boy After Kawasaki Disease.

Authors:  Brigitte Luu; Anoosh Esmaeili; Dietmar Schranz; Stephan Fichtlscherer
Journal:  Pediatr Cardiol       Date:  2015-06-11       Impact factor: 1.655

6.  Giant coronary aneurysms in Kawasaki Disease.

Authors:  Anju Gupta; Surjit Singh; Manojkumar Rohit; Deepti Suri; Amit Rawat; Nidhi Narula
Journal:  Indian J Pediatr       Date:  2013-05-03       Impact factor: 1.967

7.  The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.

Authors:  Ariane McNeal-Davidson; Anne Fournier; Rosie Scuccimarri; Adrian Dancea; Christine Houde; Marc Bellavance; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2012-06-17       Impact factor: 1.655

8.  Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention after Kawasaki Disease: The Pediatric Canadian Series.

Authors:  A Dionne; M Bakloul; C Manlhiot; B W McCrindle; M Hosking; C Houde; D Pepelassis; N Dahdah
Journal:  Pediatr Cardiol       Date:  2016-09-23       Impact factor: 1.655

9.  Coronary Artery Complications in Pediatric Patients with Kawasaki Disease: A 12-Year National Survey.

Authors:  Chun-Yen Chiang; Chung-Han Ho; Chin-Chen Chu; Zhih-Cherng Chen; Jhi-Joung Wang; Yung-Zu Tseng
Journal:  Acta Cardiol Sin       Date:  2013-07       Impact factor: 2.672

10.  Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease.

Authors:  Dibyendu Sengupta; Andrew M Kahn; Ethan Kung; Mahdi Esmaily Moghadam; Olga Shirinsky; Galina A Lyskina; Jane C Burns; Alison L Marsden
Journal:  Biomech Model Mechanobiol       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.